DREA — Anti-inflammatory Drug-Exacerbated Respiratory Disease — What tests should be done?
The manifestations associated with DREA These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "DREA — Anti-inflammatory Drug-Exacerbated Respiratory Disease — Which tests should be done?"This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
What tests are used to diagnose DREA (Anti-inflammatory Drug-Exacerbated Respiratory Disease)?
The diagnosis of Anti-inflammatory Drug-Exacerbated Respiratory Disease (ADR), a condition formerly known as Widal's Triad, involves a thorough investigation conducted by a specialist physician. The classic presentation of the disease includes the association between asthma, nasal polyposis, and hypersensitivity reactions after consuming acetylsalicylic acid (aspirin) and other nonsteroidal anti-inflammatory drugs (NSAIDs). However, it is crucial to understand that medicine does not operate with rigid and standardized patterns, as each organism has its own particularities. Often, the disease manifests gradually; for example, the patient may initially present only with recurrent nasal polyposis that does not completely resolve even after surgical interventions, without initially exhibiting all the elements of the classic triad.
To establish a safe and accurate diagnosis, the specialist physician uses a series of clinical, laboratory, and functional assessments. Among the main methods and tests used are:
- Clinical Assessment and History: Detailed analysis of respiratory symptoms, systemic reactions after ingestion of anti-inflammatory drugs — which may include reddish lesions on the body and, in severe cases, anaphylactic reactions — and the recurrence pattern of nasal polyposis.
- Pulmonary Function Test (Spirometry): Essential test for assessing respiratory impairment and identifying bronchial obstruction associated with asthma.
- Oral Aspirin Challenge Test: A highly specialized procedure that involves the controlled administration of increasing doses of aspirin to observe the emergence of spirometric changes and systemic symptoms. Due to the risk of serious reactions, this test should never be performed in low-complexity units, requiring a hospital setting or a specialized high-complexity center with immediate support.
- Complete Blood Count: Measuring the number of immune cells in peripheral blood can reveal elevated levels of eosinophils, a type of white blood cell strongly associated with allergic and inflammatory processes in DREA (Disease-Related Acute Respiratory Distress Syndrome).
- Leukotriene Dosage: Leukotriene E4 is an inflammatory mediator whose measurement can aid in diagnostic investigation, as it is closely associated with this respiratory condition.
- Nasofibroscopy: An endoscopic examination that allows the specialist to directly visualize the nasal cavity and confirm the presence of nasal polyps.
- Nasal Tissue and Nasal Polyp Biopsy: Indicated when there is strong clinical suspicion, but diagnostic doubts persist. Histopathological analysis of nasal polyp tissue may reveal the presence of eosinophilic cationic protein, as well as the presence of specific IgE directed against the bacteria. Staphylococcus aureus.
In summary, the investigation of DREA requires an integrative and thorough approach from the allergist and immunologist, correlating the patient's clinical history with laboratory findings and complementary tests. It is important to note that this content is strictly educational and informative in nature and does not, under any circumstances, replace consultation, diagnosis, and individualized medical follow-up by a qualified specialist.
Developments in Evidence-Based Medicine: Drug Hypersensitivity Reactions
According to the international consensus guidelines on drug allergy (EAACI/AAAAI/WAO), the hypersensitivity reactions to medications These reactions are divided into immediate reactions (generally occurring within the first hour to 6 hours after exposure, mediated by specific IgE or by direct activation of mast cells/cyclooxygenase-1 pathway in non-steroidal anti-inflammatory drugs, manifesting as urticaria, angioedema, bronchospasm, or anaphylaxis) and delayed reactions (mediated by specific T lymphocytes, ranging from maculopapular rashes to severe drug-induced skin reactions such as DRESS syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis). In cross-intolerance to NSAIDs and in Aspirin-Exacerbated Respiratory Disease (AED)Inhibition of the COX-1 enzyme diverts arachidonic acid metabolism toward excessive synthesis of cysteinyl leukotrienesDefining safe alternative medications and developing challenge or desensitization protocols requires an in-person evaluation at a specialized Allergy and Immunology service.
💎 Diamond Plan — Knowing exactly which medications you react to provides lifelong peace of mind. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy
Daily nasal irrigation with isotonic saline solution mechanically removes allergens, pollutants, and inflammatory mediators, enhancing the safe topical action of prescribed sprays (always applied by directing the nozzle towards the lateral wall of the nose, away from the septum). To go beyond palliative relief, perform the... allergy test allows structuring the vaccine for rhinitis within your reach with allergy vaccine, the only resource capable of re-educating the immune response to respiratory allergens.
Epithelial Barrier, Eosinophilic Inflammation, and Intestinal Permeability
Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Knowing exactly which medications you react to provides lifelong peace of mind.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to DREA It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




